Handheld device holds promise for onsite cancer diagnosis

09/7/2011 | PBS

Researchers at Michigan State University and the University of Michigan have created a handheld device called Gene-Z that they say could aid in cancer diagnosis in underserved areas. The device, which features a microfluidic chip, allows providers to analyze blood samples onsite and transmits the readings to an Android tablet, iPad or iPod Touch.

View Full Article in:

PBS

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC